Pinned
👉👉👉Delighted to share our brand new paper 📝 now online @JCO_ASCO | Final results of our Ph 1/2 #Pivekimab Sunirine (#CD123-targeted ADC) in patients with #BPDCN | ascopubs.org/doi/full/10.12… | led by @doctorpemm & @Daver_Leukemia | @MDAndersonnews #endcancer #BPDCN #leusm
















